Cationic lipophosphoramidates with two different lipid chains: synthesis and evaluation as gene carriers
作者:Stéphanie S. Le Corre、Mathieu Berchel、Nawal Belmadi、Caroline Denis、Jean-Pierre Haelters、Tony Le Gall、Pierre Lehn、Tristan Montier、Paul-Alain Jaffrès
DOI:10.1039/c3ob42270d
日期:——
The synthesis of a series of new cationic lipids possessing two different lipid chains is detailed. The transfection efficacies have shown the interest to associate a phytanyl chain with either, a lauryl or oleyl chain.
A series of dialkylphosphocholines were prepared and evaluated for their biological activity. The antiprotozoal activity was determined against Acanthamoeba lugdunensis. Compound 15 exhibited excellent trophocidal activity. None of the tested dialkylphosphocholines exhibited better fungicidal activity against Candida albicans than miltefosine. The antineoplastic activity was determined against HeLa. The most cytotoxic was compound 10, which was more active against tumor cells as against normal cells. (C) 2009 Elsevier Ltd. All rights reserved.
Autotaxin structure–activity relationships revealed through lysophosphatidylcholine analogs
作者:E. Jeffrey North、Daniel A. Osborne、Peter K. Bridson、Daniel L. Baker、Abby L. Parrill
DOI:10.1016/j.bmc.2009.03.030
日期:2009.5
Autotaxin (ATX) catalyzes the hydrolysis of lysophosphatidylcholine (LPC) to form the bioactive lipid lysophosphatidic acid (LPA). LPA stimulates cell proliferation, cell survival, and cell migration and is involved in obesity, rheumatoid arthritis, neuropathic pain, atherosclerosis and various cancers, suggesting that ATX inhibitors have broad therapeutic potential. Product feedback inhibition of ATX by LPA has stimulated structure-activity studies focused on LPA analogs. However, LPA displays mixed mode inhibition, indicating that it can bind to both the enzyme and the enzyme-substrate complex. This suggests that LPA may not interact solely with the catalytic site. In this report we have prepared LPC analogs to help map out substrate structure-activity relationships. The structural variances include length and unsaturation of the fatty tail, choline and polar linker presence, acyl versus ether linkage of the hydrocarbon chain, and methylene and nitrogen replacement of the choline oxygen. All LPC analogs were assayed in competition with the synthetic substrate, FS-3, to show the preference ATX has for each alteration. Choline presence and methylene replacement of the choline oxygen were detrimental to ATX recognition. These findings provide insights into the structure of the enzyme in the vicinity of the catalytic site as well as suggesting that ATX produces rate enhancement, at least in part, by substrate destabilization. (C) 2009 Elsevier Ltd. All rights reserved.
Synthesis of structural analogues of hexadecylphosphocholine and their antineoplastic, antimicrobial and amoebicidal activity
Twelve derivatives of hexadecylphosphocholine (miltefosine) were synthesized to determine how the position and length of the alkyl chain within the molecule influence their biological activities. The prepared alkylphosphocholines have the same molecular formula as miltefosine. Activity of the compounds was studied against a spectrum of tumour cells, two species of protozoans, bacteria and yeast. Antitumour efficacy of some alkylphosphocholines measured up on MCF-7, A2780, HUT-78 and THP-1 cell lines was higher than that of miltefosine. The compounds showed antiprotozoal activity against Acanthamoeba lugdunensis and Acanthamoeba quina. Some of them also possess fungicidal activity against Candida albicans equal to miltefosine. No antibacterial activity was observed against Staphylococcus aureus and Escherichia coil. A difference in position of a long hydrocarbon chain within the structure with maximum efficacy was observed for antitumour, antiprotozoal and antifungal activity. (C) 2015 Elsevier Masson SAS. All rights reserved.
Practical Synthesis of 3-Carboxy-(2<i>R</i>)- [[hydroxy[(tetradecyl)oxy]phosphinyl]oxy]-<i>N</i>,<i>N</i>,<i>N</i>-trimethyl-1-propanaminium Hydroxide Inner Salt (CPI975): A Carnitine Palmitoyltransferase I Inhibitor
作者:Mahavir Prashad、John C. Amedio、Lech Ciszewski、George Lee、Carmine Villa、Kau-Ming Chen、Kapa Prasad、Oljan Repič
DOI:10.1021/op020215o
日期:2002.11.1
An efficient, safe, and cost-effective synthesis of 3-carboxy-(2R)[[hydroxy[(tetradecyl)oxy]phosphinyl]oxy]-N,N,N-trimethyl-1-propanaminium hydroxide inner salt (1, CPI975), a carnitine palmitoyltransferase I inhibitor, is described. The reaction of 1-tetradecanol (2) with stoichiometric amounts Of PCl3 in THF at -15 to -20 degreesC furnished 1-tetradecyl phosphorochloridate (3). Treatment of 3 directly with L-carnitine (7) in THF in the presence of 2,4,6.collidine afforded 8, which was oxidized with bromine to afford a crude aqueous solution of 1. Desalting was done using a cheap, stable, and recyclable resin Amberlite XAD-4. The drug substance was purified by recrystallization from a mixture of ethanol and THE The yield of 1 was 65 % with 99.7% purity. Alternatively, instead of desalting with Amberlite XAD-4 resin, 1 can be isolated by an extraction with 1-decanol, followed by precipitation with acetone and recrystallization from ethanol and THF mixture.